The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 16, 2024
Filed:
Dec. 21, 2018
Applicant:
Teneobio, Inc., Thousand Oaks, CA (US);
Inventors:
Shelley Force Aldred, Thousand Oaks, CA (US);
Wim van Schooten, Thousand Oaks, CA (US);
Heather Anne N. Ogana, Thousand Oaks, CA (US);
Laura Marie Davison, Thousand Oaks, CA (US);
Katherine Harris, Thousand Oaks, CA (US);
Udaya Rangaswamy, Thousand Oaks, CA (US);
Nathan D. Trinklein, Thousand Oaks, CA (US);
Assignee:
TENEOBIO, INC., Thousand Oaks, CA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/28 (2006.01); A61P 35/00 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/2803 (2013.01); A61P 35/00 (2018.01); C07K 16/2809 (2013.01); A61K 2039/505 (2013.01); C07K 2317/31 (2013.01); C07K 2317/51 (2013.01);
Abstract
Anti-CD22 heavy chain antibodies (e.g., UniAbs™) are disclosed, along with methods of making such antibodies, compositions, including pharmaceutical compositions, comprising such antibodies, and their use to treat B cell disorders that are characterized by the expression of CD22.